The Antibody Society

the official website of the antibody society

The Adaptive Immune Receptor Repertoire Community of The Antibody Society

  • LOG IN
  • BECOME A MEMBER
  • About Us
    • Our Team
      • Directors and Officers
      • Our Staff
      • Our Committees
    • Sponsors & Partners
  • Events Calendar
    • Current Events
  • AIRR Community
    • AIRR Community News
    • AIRR Community Newsletter
    • AIRR Community Seminar Series
    • AIRR Community Meetings
      • AIRR Community Meeting VIII – Decoding and Recoding Immunity
      • Zooming into the Community III
      • AIRR Community Meeting VII – Learnings and Perspectives
      • AIRR Community Special Event 2023  – Zooming in to the Community II
      • AIRR Community Meeting VI: “Exploring New Frontiers”
      • AIRR Community Meeting V: “Zooming in to the AIRR Community”
      • AIRR Community Meeting V Pre-Meetings
        • AIRR-seq in the Pandemic
        • AIRR-seq Biological Standards and Workflows
      • AIRR Community Special Event: “Response to COVID-19”
      • AIRR Community Meeting IV: “Bridging the Gaps”
      • AIRR Community Meeting III
        • Day 1
        • Day 2
        • Day 3
        • Day 4
      • AIRR Community Meeting II
      • AIRR Community Meeting I
    • On AIRR – An AIRR Community Podcast
    • AIRR Data Commons
    • AIRR-C Germline Database Resources
    • AIRR Community Publications
    • AIRR Community Working Groups
      • Biological Resources Working Group
      • Common Repository Working Group
      • Diagnostics Working Group
      • Germline Database Working Group
      • Legal and Ethics Working Group
      • Software Working Group
      • Standards Working Group
    • AIRR Community Sub-Committees
      • Communications Sub-Committee
      • Executive Sub-Committee
      • Inferred Allele Review Committee
      • Meetings Sub-Committee
      • Strategic Planning Sub-Committee
    • AIRR Community Webinar Series
    • AIRR Community Calendar
    • AIRR Community Resources
  • Programs
    • Conferences
    • Competitions
      • Huston Award
        • Huston Award submission guidelines
      • Research Competition
      • Science Writing
    • Podcast
    • Webinars
  • Business Intelligence
    • Antibody Discovery & Development
      • Antibody Validation
      • Commercializing Antibody Therapeutics
      • Adaptive Immune Receptor Repertoires
    • Antibody News
    • Antibody therapeutics approved or in regulatory review in the EU or US
      • Antibody therapeutics product data
    • Antibodies to Watch
      • Antibodies in early-stage studies
    • Presentations
  • Learning and Career Center
    • Research Resources
      • Antibodies in late-stage clinical studies
    • Education Resources
    • Society Publications
    • Career Shorts
  • Members
    • Login
    • Note to members
    • Member discount codes
  • Sponsors & Partners
You are here: Home / The AIRR Community / AIRR Community Sub-Committees / Inferred Allele Review Sub-committee (IARC)

Inferred Allele Review Sub-committee (IARC)

The Inferred Allele Review Sub-committee (IARC) was formed after the third AIRR-Community meeting in Rockville, MD in December 2017. The IARC is responsible for judging the validity of germline immunoglobulin and TCR genes inferred from AIRR-Seq and genomic data and submitting their findings to the IUIS T-cell Receptor and Immunoglobulin Nomenclature Review Committee.  The work of the committee initially focused on human IGHV germline genes, but it is hoped that work will commence on the evaluation of other germline genes and species. Overall, the IARC aims to generate resources for and advocate for better practice in and understanding of IG and TR annotation and analysis in the community interested in studies of AIRR. 

Achievements

  • Process to enable move for integration of genomic and transcriptomic data
    • Establish principle for review of genomic data
  • Working with researchers and other AIRR-C groups to
    • Establish macaque reference set
    • Establish TCR reference set
    • Integrate genomic data in the IARC process
      • Establish lambda light chain reference set
      • Establish TCR reference set
    • Work with teams exploiting new technologies
  • Review submitted to Immunoinformatics
  • Expansion of competence in AIRR data of additional species

Further details, including evidence in support of the inferences, can be found at the OGRDB website.

Goals for 2024-26

  • Evolve from sub-committee to review committee
  • Incorporate genomic data in processes; process for larger submissions
  • Consolidate interaction with TR-IG/IUIS nomenclature subcommittee
  • Consolidation of the human TCR IARC process

Members

Co-leader: Mats Ohlin and Ayelet Peres

Members: 11 members

Products

Over all: Database for alleles of germline genes (continuous) and reference sets (through collaboration)

  • 9 inferred immunoglobulin alleles submitted to and approved by IUIS
  • A published commentary on the use of short read sequencing for AIRR allele discovery
  • A submitted manuscript on Balb/c germline alleles identified by inference (co-authored with other WGs)
  • Germline gene sets for Balb/c and C57BL/6 mouse strains published on OGRDB

Related Resources

  • The OGRDB database documents the evaluation process of each submitted gene sequence, and provides access to evidence in support of affirmed inferences. 
  • The VDJbase database of genotypes and haplotypes is being developed in association with OGRDB, and provides evidence of the expression of germline genes in hundreds of individuals.
  • Discussion of some issues arising from activities of the Germline Database Working Group can be found at the B-T.CR Wiki.

Meeting Minutes

2024:

  • IARC Meeting 133 Minutes – 2024/02/26
  • IARC Meeting 132 Minutes – 2024/02/12

Archives:

  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018

Contact

iarc@airr-community.org
  • Home
  • Privacy & Terms of Use
  • About
  • Directors and Officers
  • Advisors
  • Sponsors & Partners Old
  • Mission & Activities
  • Join the Society
  • Membership Levels
  • Members
  • Login
  • Antibody therapeutics approved or in regulatory review in the EU or US
  • Meeting reports
  • Presentations
  • Contact

©2015 - scicomvisuals